Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CRBPCRBP
10 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CORBUS PHARMACEUTICALS HOLDINGS INC

Yes. Goldman Sachs holds 62,863 shares of CRBP (Corbus Pharmaceuticals Holdings), worth $589,655, as of its Q2 2026 13F filing. It reduced the position by 30,248 shares (-32.5%) from Q1 2026. Goldman Sachs has held CRBP since Q1 2024, across 10 quarterly 13F filings.

Current Value

$589,655

Current Shares

62,863

Total Value Change

-$3.6M

Total Shares Change

-43,515

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
62,863
-32.5%
$589,6550.0%$9.38
0
2026-Q1
Increased
93,111
+96.3%
$874,3130.0%$9.39
40
2025-Q4
Increased
47,438
+42.2%
$386,1450.0%$8.14
22
2025-Q3
Decreased
33,352
-23.6%
$421,9030.0%$12.65
0
2025-Q2
Decreased
43,674
-24.6%
$301,3510.0%$6.90
0
2025-Q1
Increased
57,936
+1.3%
$307,6410.0%$5.31
16
2024-Q4
Increased
57,174
+15.7%
$674,6530.0%$11.80
28
2024-Q3
Decreased
49,420
-18.4%
$1M0.0%$20.63
0
2024-Q2
Decreased
60,528
-43.1%
$2.7M0.0%$45.25
0
2024-Q1
New
106,378
-
$4.2M0.0%$39.24
37

Other major holders of CRBP: BlackRock Finance, Inc., Point72 Asset Management, L.P., STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used